Small molecule. Big biology. Dual phosphatase inhibitor enters the immunotherapy fray
Immunology & Cell Biology · 2024
DOI: 10.1111/imcb.12711 ↗Kurz gefasst
Kommentar in der Zeitschrift Immunology & Cell Biology, 2024. Verfasst von Nicholas S Wilson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Bristol Myers Squibb, Cancer Immunology and Cell Therapy Thematic Research Centre, Redwood City, CL, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
The advent and clinical success of immune checkpoint inhibitors Ipilimumab, Nivolumab and Pembrolizumab has had a seismic impact on our drug discovery focus and rationale. Novel extrinsic targets that enhance immune responses to cancer are actively being pursued, while tumor intrinsic targets that render cancer cells more sensitive to the immune system have joined traditional intrinsic targets (e.g. directly cytotoxic) in the drug discovery pipeline. The phosphatase PTPN2 (TC‐PTP) and its paralog PTPN1 (PTP‐1B) are negative regulators of several cytokine signaling pathways and T cell receptor (TCR) signaling. In a recent publication, Baumgartner et al. demonstrate the pre‐clinical efficacy of a first‐in‐class dual PTPN1/N2 active site inhibitor (ABBV‐CLS‐484/AC484) in cancer models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bristol Myers Squibb, Cancer Immunology and Cell Therapy Thematic Research Centre, Redwood City, CL, USA.
- oNKo-Innate Pty Ltd, Melbourne, VIC, 3000, Australia.
ORCID-Profile: Nicholas D Huntington
Zitieren
APA
Wilson, N. S., & Huntington, N. D. (2024). Small molecule. Big biology. Dual phosphatase inhibitor enters the immunotherapy fray. Immunology & Cell Biology. https://doi.org/10.1111/imcb.12711
Vancouver
Wilson NS, Huntington ND. Small molecule. Big biology. Dual phosphatase inhibitor enters the immunotherapy fray. Immunology & Cell Biology. 2024. doi:10.1111/imcb.12711
BibTeX
@article{Wilson2024,
author = {Wilson, Nicholas S and Huntington, Nicholas D},
title = {Small molecule. Big biology. Dual phosphatase inhibitor enters the immunotherapy fray},
journal = {Immunology & Cell Biology},
year = {2024},
doi = {10.1111/imcb.12711}
}
EUVIMED